ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,631,538 | -10.9% | 134,377 | +1.3% | 0.00% | 0.0% |
| Q2 2023 | $4,074,400 | +349.7% | 132,695 | +428.6% | 0.00% | +300.0% |
| Q1 2023 | $906,003 | -97.0% | 25,104 | -96.8% | 0.00% | -97.1% |
| Q4 2022 | $30,270,660 | +60.3% | 775,177 | +66.2% | 0.04% | +12.9% |
| Q3 2022 | $18,885,000 | +92.3% | 466,526 | +99.4% | 0.03% | +121.4% |
| Q2 2022 | $9,821,000 | +927.3% | 233,992 | +794.3% | 0.01% | +1300.0% |
| Q3 2021 | $956,000 | +36.6% | 26,164 | +54.4% | 0.00% | 0.0% |
| Q2 2021 | $700,000 | -22.1% | 16,947 | -7.6% | 0.00% | 0.0% |
| Q4 2020 | $899,000 | +247.1% | 18,341 | +204.0% | 0.00% | – |
| Q3 2020 | $259,000 | – | 6,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |